During the past decade, Manning Base Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Manning Base Hospital" #1 collaborator was "Breast International Group" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Manning Base Hospital" are "Fallopian Tube Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Primary Peritoneal Cavity Cancer" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Manning Base Hospital" in a lesser frequency.

Most popular intervention types in "Manning Base Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (1 trials), "erlotinib hydrochloride" (1 trials), "exemestane" (1 trials), "tamoxifen" (1 trials) and "triptorelin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Manning Base Hospital" are 3 trials for "Female" genders.

Currently, there are NaN active trials in "Manning Base Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Manning Base Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Manning Base Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".